CoChat

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index; 7 of the 95 sources its claims cite were checked for support.

Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum

Open access

Abstract

Dietary fiber supplements are a strategy to close the ‘fiber gap’ and induce targeted modulations of the gut microbiota. However, higher doses of fiber supplements cause gastrointestinal (GI) symptoms that differ among individuals. What determines these inter-individual differences is insufficiently understood. Here we analyzed findings from a six-week randomized controlled trial that evaluated GI symptoms to corn bran arabinoxylan (AX; n = 15) relative to non-fermentable microcrystalline cellulose (MCC; n = 16) at efficacious supplement doses of 25 g/day (females) or 35 g/day (males) in adults with excess weight. Self-reported flatulence, bloating, and stomach aches were evaluated weekly. Bacterial taxa involved in AX fermentation were identified by bioorthogonal non-canonical amino acid tagging. Associations between GI symptoms, fecal microbiota features, and diet history were systematically investigated. AX supplementation increased symptoms during the first three weeks relative to MCC (p < 0.05, Mann-Whitney tests), but subjects ‘adapted’ with symptoms reverting to baseline levels toward the end of treatment. Symptom adaptations were individualized and correlated with the relative abundance of Bifidobacterium longum at baseline (rs = 0.74, p = 0.002), within the bacterial community that utilized AX (rs = 0.69, p = 0.006), and AX-induced shifts in acetate (rs = 0.54, p = 0.039). Lower baseline consumption of animal-based foods and higher whole grains associated with less severity and better adaptation. These findings suggest that humans do ‘adapt’ to tolerate efficacious fiber doses, and this process is linked to their microbiome and dietary factors known to interact with gut microbes, providing a basis for the development of strategies for improved tolerance of dietary fibers.

Overview

CoChat Summary

## TL;DR

In this 6-week exploratory randomized controlled trial, high-dose long-chain corn bran arabinoxylan (AX) caused moderate gastrointestinal symptoms versus microcrystalline cellulose, but most participants adapted within the intervention period. Better AX tolerance was associated with higher fecal abundance of *Bifidobacterium longum*, greater fecal acidification/acetate, and a more plant-forward baseline diet.

## Key findings

  • Thirty-eight volunteers with excess weight were enrolled; 31 completed and were analyzed per protocol (21 females, 10 males), with AX given at 25 g/day for females and 35 g/day for males over 6 weeks.
  • AX increased overall symptoms, flatulence, bloating, stomach ache, and composite GI scores versus microcrystalline cellulose (generalized estimated equation models, treatment effect *p* < 0.05). Flatulence AUC severity was higher for AX (*p* = 0.045), and composite AUC severity trended higher (*p* < 0.1).
  • Symptoms improved over time during AX: flatulence, bloating, stomach ache, and composite ratings at week 6 were lower than the peak values, and weeks 1–3 were significantly worse than weeks 4–6 for flatulence and composite scores (*p* = 0.02 for both), indicating adaptation within 6 weeks.
  • Higher fecal *B. longum* abundance was associated with better AX tolerance: during AX, *B. longum* correlated negatively with composite severity (*r*ₛ = -0.48, *p* = 0.007) and bloating severity (*r*ₛ = -0.54, *p* = 0.002); baseline *B. longum* also correlated with lower bloating AUC severity (*r*ₛ = -0.67, *p* = 0.007) and better composite AUC adaptation (*r*ₛ = 0.74, *p* = 0.002).
  • Fecal acidification and SCFA shifts also tracked with tolerance: fecal acidification correlated with lower composite AUC severity for AX (*r*ₛ = 0.54, *p* = 0.039), and composite AUC adaptation correlated with total SCFAs (*r*ₛ = 0.55, *p* = 0.036) and acetate (*r*ₛ = 0.54, *p* = 0.039).
  • A more plant-forward baseline diet was linked to better AX tolerance: a higher meat/meat alternatives to whole grains ratio correlated with higher composite (*r*ₛ = 0.68, *p* = 0.007) and flatulence (*r*ₛ = 0.70, *p* = 0.005) AUC severity and lower composite AUC adaptation (*r*ₛ = -0.54, *p* = 0.042).

## Methods

  • Exploratory 6-week RCT registered as NCT02322112; participants with excess weight were assigned to AX or non-fermentable microcrystalline cellulose control, with daily doses of 25 g (females) or 35 g (males).
  • Per-protocol sample: 31 completers aged 33 ± 9 years with BMI 28.7 ± 2.3 kg/m²; baseline diet was assessed by the Canadian Diet History Questionnaire II, adjusted for total calories.
  • GI symptoms were rated weekly on 0–4 scales for overall symptoms, flatulence, bloating, and stomach ache; severity and adaptation were quantified using MAX and AUC-based scores. Associations with fecal microbiota, fecal pH/SCFAs, and baseline diet were tested using generalized estimating equations, Mann-Whitney/Wilcoxon tests, and Spearman correlations; BONCAT plus 16S rRNA sequencing was used to identify AX-active bacterial consortia.

## Limitations

  • The paper states this was an exploratory RCT and notes that the design does not allow causal inferences between symptom adaptation and the gut microbiota.
  • The authors also state that future studies are needed, including more sophisticated methods such as whole-metagenome/shotgun sequencing with ingestible gas-sensing capsules, to evaluate mechanisms of adaptation.
  • Evident from the text: the AX and MCC groups were compared using data from protocol completers rather than all enrolled participants, and several analyses rely on correlations across a small sample (31 completers), which limits generalizability and causal interpretation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/19490976.2024.2363021

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Study design.
Figure 1. Study design.CC BY · PubMed Central
Figure 2. Symptoms in response to AX consumption and adaptation toward AX as compared to MCC consumption.
Figure 2. Symptoms in response to AX consumption and adaptation toward AX as compared to MCC consumption.CC BY · PubMed Central
Figure 3. Associations between symptom severity and bacterial abundance during AX and MCC consumption.
Figure 3. Associations between symptom severity and bacterial abundance during AX and MCC consumption.CC BY · PubMed Central
Figure 4. Improved composite scores during AX consumption were linked to the relative abundance of Bifidobacterium longum.
Figure 4. Improved composite scores during AX consumption were linked to the relative abundance of Bifidobacterium longum.CC BY · PubMed Central
Figure 5. Shifts in fecal pH and SCFA concentrations correlated with the severity and adaptation of AX- and MCC-induced symptom.
Figure 5. Shifts in fecal pH and SCFA concentrations correlated with the severity and adaptation of AX- and MCC-induced symptom.CC BY · PubMed Central
Figure 6. Baseline diet history correlated with symptom severity and adaptation during AX and MCC consumption.
Figure 6. Baseline diet history correlated with symptom severity and adaptation during AX and MCC consumption.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 45 Not checked · 66 Own results and interpretations

42 more claims

Create a free account to see all 116 claims and to verify the 88 references still open.

See all claims — free account
  • Probably not a substantial claim. 37
  • It may state two separate claims as one. 47
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 75 references

Cited by

See all 15

Metadata

Authors
Deehan, E. C., Zhang, Z., Nguyen, N. K., Perez-Muñoz, M. E., Cole, J., Riva, A., Berry, D., Prado, C. M., & Walter, J.
Affiliations
  • University of Nebraska–Lincoln (US)
  • University of Alberta (CA)
  • Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada
  • University of Vienna (AT)
Corresponding author
  • Deehan, Edward C.
  • Walter, Jens
Venue
Gut Microbes
Published
2024-06-11
Volume
16
Issue
1
Pages
2363021-2363021
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4399529977
Cited by
15
References
75
Citations by year
2026: 7 · 2025: 7 · 2024: 1
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lincoln (University of Nebraska) (submittedVersion)
  • Digital Access to Libraries (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Research Council (FunKeyGut 741623)
  • Canadian Institutes of Health Research
  • Science Foundation Ireland Centre (APC/SFI/12/RC/2273_P2)
  • Science Foundation Ireland Professorship (19/RP/6853)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords
arabinoxylan, Bifidobacterium longum, gut microbiota, gastrointestinal symptoms, acetate, dietary fiber fermentation, microcrystalline cellulose, whole grains, overweight
MeSH terms
Gastrointestinal Microbiome, Bifidobacterium longum, Adaptation, Physiological, Adult, Aged, Dietary Fiber, Feces, Female, Fermentation, Humans, Male, Middle Aged, Xylans, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum. https://app.cochat.ai/papers/10.1080/19490976.2024.2363021
The paper
Deehan, E. C., Zhang, Z., Nguyen, N. K., Perez-Muñoz, M. E., Cole, J., Riva, A., Berry, D., Prado, C. M., & Walter, J. (2024). Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum. Gut Microbes. https://doi.org/10.1080/19490976.2024.2363021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.